Liubov Kozlovskaya
Liubov Kozlovskaya
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
bSechenov Moscow State Medical University, Moscow 119991, Russia
a,b,⁎,
Anastasia Piniaeva
Anastasia Piniaeva
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
a,
Georgy Ignatyev
Georgy Ignatyev
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
a,
Alexey Selivanov
Alexey Selivanov
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
a,
Anna Shishova
Anna Shishova
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
bSechenov Moscow State Medical University, Moscow 119991, Russia
a,b,
Anastasia Kovpak
Anastasia Kovpak
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
a,
Ilya Gordeychuk
Ilya Gordeychuk
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
bSechenov Moscow State Medical University, Moscow 119991, Russia
a,b,
Yury Ivin
Yury Ivin
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
a,
Anastasia Berestovskaya
Anastasia Berestovskaya
cGKB No. 40 DZM, Moscow 129301, Russia
c,
Egor Prokhortchouk
Egor Prokhortchouk
eInstitute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia
e,
Denis Protsenko
Denis Protsenko
cGKB No. 40 DZM, Moscow 129301, Russia
c,
Mikhail Rychev
Mikhail Rychev
dNRC “Kurchatov Institute”, Moscow 123182, Russia
d,
Aydar Ishmukhametov
Aydar Ishmukhametov
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
bSechenov Moscow State Medical University, Moscow 119991, Russia
a,b
aFSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia
bSechenov Moscow State Medical University, Moscow 119991, Russia
cGKB No. 40 DZM, Moscow 129301, Russia
dNRC “Kurchatov Institute”, Moscow 123182, Russia
eInstitute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia
⁎Corresponding author at: FSBSI “Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences” (FSBSI “Chumakov FSC R&D IBP RAS”), Moscow 108819, Russia.
© 2020 The Author(s)
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.